Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas

NCT00053040 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
NETWORK
Sponsor class

Stopped Withdrawal of pharmaceutical company support for the investigational drug

Conditions

Interventions

Sponsor

Pediatric Brain Tumor Consortium

Collaborators